Fluorouracil (Solco Healthcare US LLC)
Welcome to the PulseAid listing for the Fluorouracil drug offered from Solco Healthcare US LLC. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Solco Healthcare US LLC |
NON-PROPRIETARY NAME: | Fluorouracil |
SUBSTANCE NAME: | FLUOROURACIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | TOPICAL |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2010-06-01 |
END MARKETING DATE: | 0000-00-00 |
Fluorouracil HUMAN PRESCRIPTION DRUG Details:
Item Description | Fluorouracil from Solco Healthcare US LLC |
LABELER NAME: | Solco Healthcare US LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/mL) |
START MARKETING DATE: | 2010-06-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 43547-258_f11232f0-6ba0-4719-94cd-6f04562f2542 |
PRODUCT NDC: | 43547-258 |
APPLICATION NUMBER: | NDA016831 |
Other FLUOROURACIL Pharmaceutical Manufacturers / Labelers: